Adiponectin receptor 1 regulates endometrial receptivity via the adenosine monophosphate-activated protein kinase/E-cadherin pathway

被引:0
|
作者
Sarankhuu, Bolor-Erdene [1 ]
Jeon, Hye Jin [1 ]
Jeong, Da-Un [1 ]
Park, Seok-Rae [1 ,2 ]
Kim, Tae-Hyun [1 ,3 ]
Lee, Sung Ki [1 ,3 ]
Han, Ae Ra [4 ,5 ]
Yu, Seong-Lan [1 ]
Kang, Jaeku [1 ,6 ]
机构
[1] Konyang Univ, Myunggok Med Res Inst, Coll Med, Prior Res Ctr, 158 Gwanjeodong Ro, Daejeon 35365, South Korea
[2] Konyang Univ, Coll Med, Dept Microbiol, Daejeon 35365, South Korea
[3] Konyang Univ Hosp, Coll Med, Dept Obstet & Gynecol, Daejeon 35365, South Korea
[4] Mizmedi Hosp, Dept Obstet & Gynecol, I Dream Clin, Seoul 07639, South Korea
[5] CHA Univ, Daegu CHA Fertil Ctr, Daegu 42469, North Gyeongsan, South Korea
[6] Konyang Univ, Coll Med, Dept Pharmacol, 158 Gwanjeodong Ro, Daejeon 35365, South Korea
基金
新加坡国家研究基金会;
关键词
endometrial receptivity; adiponectin receptor 1; AMP-activated protein kinase; E-cadherin; dorsomorphin; 5-aminoimidazole-4-carboxamide ribonucleotide; AMPK KNOCKDOWN; CELLS; EXPRESSION;
D O I
10.3892/mmr.2024.13308
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Endometrial receptivity is essential for successful embryo implantation and pregnancy initiation and is regulated via various signaling pathways. Adiponectin, an important adipokine, may be a potential regulator of reproductive system functions. The aim of the present study was to elucidate the regulatory role of adiponectin receptor 1 (ADIPOR1) in endometrial receptivity. The endometrial receptivity between RL95-2 and AN3CA cell lines was confirmed using an in vitro JAr spheroid attachment model. 293T cells were transfected with control or short hairpin (sh)ADIPOR1 vectors and RL95-2 cells were transduced with lentiviral particles targeting ADIPOR1. Reverse transcription-quantitative PCR and immunoblot assays were also performed. ADIPOR1 was consistently upregulated in the endometrium during the mid-secretory phase compared with that in the proliferative phase and in receptive RL95-2 cells compared with that in non-receptive AN3CA cells. Stable cell lines with diminished ADIPOR1 expression caused by shRNA showed reduced E-cadherin expression and attenuated in vitro endometrial receptivity. ADIPOR1 regulated AMP-activated protein kinase (AMPK) activity in endometrial epithelial cells. Regulation of AMPK activity via dorsomorphin and 5-aminoimidazole-4-carboxamide ribonucleotide affected E-cadherin expression and in vitro endometrial receptivity. The ADIPOR1/AMPK/E-cadherin axis is vital to endometrial receptivity. These findings can help improve fertility treatments and outcomes.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Angiotensin II suppresses adenosine monophosphate-activated protein kinase of podocytes via angiotensin II type 1 receptor and mitogen-activated protein kinase signaling
    Ji-Young Choi
    Tae-Sun Ha
    Hye-Young Park
    Hee-Yul Ahn
    Clinical and Experimental Nephrology, 2013, 17 : 16 - 23
  • [22] Angiotensin II suppresses adenosine monophosphate-activated protein kinase of podocytes via angiotensin II type 1 receptor and mitogen-activated protein kinase signaling
    Choi, Ji-Young
    Ha, Tae-Sun
    Park, Hye-Young
    Ahn, Hee-Yul
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2013, 17 (01) : 16 - 23
  • [23] Role of the Peroxisome Proliferator-Activated Receptors, Adenosine Monophosphate-Activated Kinase, and Adiponectin in the Ovary
    Dupont, Joelle
    Chabrolle, Christine
    Rame, Christelle
    Tosca, Lucie
    Coyral-Castel, Steephanie
    PPAR RESEARCH, 2008, 2008
  • [24] Xylazine Activates Adenosine Monophosphate-Activated Protein Kinase Pathway in the Central Nervous System of Rats
    Shi, Xing-Xing
    Yin, Bai-Shuang
    Yang, Peng
    Chen, Hao
    Li, Xin
    Su, Li-Xue
    Fan, Hong-Gang
    Wang, Hong-Bin
    PLOS ONE, 2016, 11 (04):
  • [25] Apelin-13 Reverses Bupivacaine-Induced Cardiotoxicity via the Adenosine Monophosphate-Activated Protein Kinase Pathway
    Ye, Yingchao
    Cai, Yaoyao
    Xia, Erjie
    Shi, Kejian
    Jin, Zhousheng
    Chen, Hongfei
    Xia, Fangfang
    Xia, Yun
    Papadimos, Thomas J.
    Xu, Xuzhong
    Liu, Le
    Wang, Quanguang
    ANESTHESIA AND ANALGESIA, 2021, 133 (04): : 1048 - 1059
  • [26] Role of adenosine monophosphate-activated protein kinase in the control of energy homeostasis
    Foufelle, F
    Ferré, P
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2005, 8 (04): : 355 - 360
  • [27] Vascular adenosine monophosphate-activated protein kinase: Enhancer, brake or both?
    Chen, Hui
    Vanhoutte, Paul Michel
    Leung, Susan Wai Sum
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 127 (02) : 81 - 91
  • [28] 5′ Adenosine Monophosphate-Activated Protein Kinase Modulators as Anticancer Agents
    Thakur, Abhishek
    Dan, Nirnoy
    Bhakat, Soumendranath
    Jayaprakash, Venkatesan
    Banerjee, Sugato
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2016, 16 (08) : 961 - 972
  • [29] Diabetic conditions modulate the adenosine monophosphate-activated protein kinase of podocytes
    Ha, Tae-Sun
    Park, Hye-Young
    Nam, Ja-Ae
    Han, Gi-Dong
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2014, 33 (01) : 26 - 32
  • [30] Metabolic syndrome: Adenosine monophosphate-activated protein kinase and malonyl coenzyme A
    Ruderman, Neil B.
    Saha, Asish K.
    OBESITY, 2006, 14 : 25S - 33S